TNBC pipeline landscape

344 active TNBC programs by approach and stage.

Pipeline View

Small moleculeOligonucleotideGene / cell therapyAntibody / biologicUndisclosedRepurposingPossibly inactiveClick a chip for details
Setting:
Active TNBC programs by modality and stage
ModalityPreclinicalINDPhase 1Phase 2Phase 3+Approved
Targeted payload delivery
Checkpoint and T-cell activation
Innate immunity and tumor microenvironment
Cell therapies and vaccines
DNA damage response
Epigenetic and transcriptional
Growth signaling and cell cycle
Cell death and metabolism
Cytotoxic and anti-angiogenic
Undisclosed
Repurposing